[Norwegian scabies in a patients with dystrophic epidermolysis bullosa].
Toth
G G
GG
Van der Wal
V B
VB
Van Voorst Vader
P C
PC
Jonkman
M F
MF
D000293:Adolescent; D000900:Anti-Bacterial Agents; D001803:Blood Transfusion; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D016108:Epidermolysis Bullosa Dystrophica / Q000150:complications*; D005260:Female; D006801:Humans; D007306:Insecticides / Q000627:therapeutic use; D012532:Scabies / Q000150:complications* / Q000188:drug therapy / Q000628:therapy*; D018805:Sepsis / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D012867:Skin / Q000473:pathology; D013983:Tick Control / Q000379:methods; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D007306:Insecticides